GENOMIC STABILITY AND WILD-TYPE P53 FUNCTION OF LYMPHOBLASTOID-CELLS WITH GERM-LINE P53 MUTATION

被引:0
|
作者
LALLE, P
MOYRETLALLE, C
WANG, Q
VIALLE, JM
NAVARRO, C
BRESSACDEPAILLERETS, B
MAGAUD, JP
OZTURK, M
机构
[1] CTR LEON BERARD, INSERM, CJF 9302, ONCOL MOLEC LAB, F-69373 LYON 08, FRANCE
[2] HOP EDOUARD HERRIOT, INSERM, CJF 9307, CENT HEMATOL & CYTOGENET LAB, F-69437 LYON, FRANCE
[3] INST GUSTAVE ROUSSY, DIAGNOST MOLEC LAB, F-94805 VILLEJUIF, FRANCE
关键词
P53; LI-FRAUMENI SYNDROME; EPSTEIN-BARR VIRUS; LYMPHOBLASTOID CELLS; GENOMIC STABILITY;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increased cancer risk associated with germ-line p53 mutation was linked to a deficit in the ability to maintain genomic stability. Accordingly, normal fibroblasts from cancer-prone individuals accumulate genomic aberrations with concomitant loss of mild-type p53 allele during in vitro culture. We tested whether such changes also occur in EBV-immortalized lymphoblastoid cells. Both normal and p53 germ-line mutant lymphoblastoid cells maintained functional p53 and genomic stability during long term in vitro culture. These unexpected differences between fibroblastic and lymphoblastic cells suggest that phenotypic expression of p53 deficiency is cell type specific. This could contribute to selective tissular localization of tumours observed in patients with Li-Fraumeni syndrome despite the presence of a mutant p53 allele in all cells.
引用
收藏
页码:2447 / 2454
页数:8
相关论文
共 50 条
  • [31] Thermodynamic stability of wild-type and mutant p53 core domain
    Bullock, AN
    Henckel, J
    DeDecker, BS
    Johnson, CM
    Nikolova, PV
    Proctor, MR
    Lane, DP
    Fersht, AR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14338 - 14342
  • [32] Thermodynamic stability of wild-type and mutant p53 core domain
    Proc Natl Acad Sci USA, 26 (14338):
  • [33] Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation
    De Smet, Frederik
    Rubio, Mirian Saiz
    Hompes, Daphne
    Naus, Evelyne
    De Baets, Greet
    Langenberg, Tobias
    Hipp, Mark S.
    Houben, Bert
    Claes, Filip
    Charbonneau, Sarah
    Blanco, Javier Delgado
    Plaisance, Stephane
    Ramkissoon, Shakti
    Ramkissoon, Lori
    Simons, Colinda
    van den Brandt, Piet
    Weijenberg, Matty
    Van England, Manon
    Lambrechts, Sandrina
    Amant, Frederic
    D'Hoore, Andre
    Ligon, Keith L.
    Sagaert, Xavier
    Schymkowitz, Joost
    Rousseau, Frederic
    JOURNAL OF PATHOLOGY, 2017, 242 (01): : 24 - 38
  • [34] INTRODUCTION OF WILD-TYPE P53 IN A HUMAN OVARIAN-CANCER CELL-LINE NOT EXPRESSING ENDOGENOUS P53
    VIKHANSKAYA, F
    ERBA, E
    DINCALCI, M
    BROGGINI, M
    NUCLEIC ACIDS RESEARCH, 1994, 22 (06) : 1012 - 1017
  • [35] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    Palacios, G.
    Moll, U. M.
    ONCOGENE, 2006, 25 (45) : 6133 - 6139
  • [36] Okadaic acid mediates p53 hyperphosphorylation and growth arrest in cells with wild-type p53 but increases aberrant mitoses in cells with non-functional p53
    Milczarek, GJ
    Chen, WX
    Gupta, A
    Martinez, JD
    Bowden, GT
    CARCINOGENESIS, 1999, 20 (06) : 1043 - 1048
  • [37] Interaction of p53 with the CCT Complex Promotes Protein Folding and Wild-Type p53 Activity
    Trinidad, Antonio Garcia
    Muller, Patricia A. J.
    Cuellar, Jorge
    Klejnot, Marta
    Nobis, Max
    Maria Valpuesta, Jose
    Vousden, Karen H.
    MOLECULAR CELL, 2013, 50 (06) : 805 - 817
  • [38] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    G Palacios
    U M Moll
    Oncogene, 2006, 25 : 6133 - 6139
  • [39] Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
    Atencio, IA
    Avanzini, JB
    Johnson, D
    Neuteboom, S
    Vaillancourt, MT
    Nielsen, LL
    Hajian, G
    Sutjipto, S
    Sugarman, BJ
    Philopena, J
    McAllister, DL
    Beltran, JC
    Nodelman, M
    Ramachandra, M
    Wills, KN
    MOLECULAR THERAPY, 2001, 4 (01) : 5 - 12
  • [40] REGULATION OF THE STRUCTURE AND FUNCTION OF WILD-TYPE AND MUTANT FORMS OF P53
    BARGONETTI, J
    CHEN, XB
    FARMER, G
    FRIEDLANDER, P
    JAYARAMAN, L
    MANFREDI, J
    MILLER, S
    WANG, Y
    PRIVES, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 162 - 162